The Wagner Firm Reminds Investors of May 16th Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc.

Investors with losses of over $50,000 are encouraged to contact the firm.

LOS ANGELES--()--The Wagner Firm reminds investors of the May 16, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the “Class”) of investors who purchased or otherwise acquired Insys Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY) securities between February 23, 2016 and March 15, 2017, inclusive (the “Class Period”). Insys investors have until May 16, 2017 to file a lead plaintiff motion.

On March 15, 2017, Insys disclosed that it would delay the release of its financial results for the fourth quarter and full year 2016 in order to complete an independent review of the Company’s processes related to sales allowances and extended payment terms. The company further disclosed that the review could result in a reduction of 2015 net revenue and pre-tax income. On this news, shares of Insys fell nearly 5% during trading on March 16, 2017 to close at $10.06 per share, thereby injuring investors.

The Complaint filed in this class action lawsuit alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Insys had overstated its 2015 net revenue; (ii) Insys had misstated its sales allowances for 2016; (iii) accordingly, the Company lacked effective internal controls over financial reporting; and (iv) as a result of the foregoing, Insys’ public statements were materially false and misleading at all relevant times.

If you purchased or otherwise acquired Insys shares during the Class Period, you may move the Court no later than May 16, 2017 to request appointment as lead plaintiff. To be a member of the class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Avi Wagner, Esquire, of The Wagner Firm, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, at (310) 491-7949, by e-mail at info@thewagnerfirm.com, or visit our website at http://thewagnerfirm.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Wagner Firm, Los Angeles, CA
Avi Wagner, (310) 491-7949
info@thewagnerfirm.com
www.thewagnerfirm.com

Recent Stories

RSS feed for The Wagner Firm

Release Summary

The Wagner Firm Reminds Investors of May 16th Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc.

The Wagner Firm